These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20149159)

  • 21. Chronic rejection in renal transplant recipients--risk factors and correlates.
    Matas A
    Clin Transplant; 1994 Jun; 8(3 Pt 2):332-5. PubMed ID: 8061376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.
    Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
    Exp Clin Transplant; 2009 Jun; 7(2):104-9. PubMed ID: 19715514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum phosphate predicts mortality in renal transplant recipients.
    Connolly GM; Cunningham R; McNamee PT; Young IS; Maxwell AP
    Transplantation; 2009 Apr; 87(7):1040-4. PubMed ID: 19352125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The independent association between serum uric acid and graft outcomes after kidney transplantation.
    Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
    Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of recipient age on the clinical course of renal transplantation].
    Palomar R; Ruiz JC; Cotorruelo JG; Zubimendi JA; de Francisco AL; Rodrigo E; Sanz S; Arias M
    Nefrologia; 2001; 21(4):386-91. PubMed ID: 11816515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma bilirubin and late graft failure in renal transplant recipients.
    Deetman PE; Zelle DM; Homan van der Heide JJ; Navis GJ; Gans RO; Bakker SJ
    Transpl Int; 2012 Aug; 25(8):876-81. PubMed ID: 22716194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation.
    van Ree RM; de Vries AP; Oterdoom LH; Seelen MA; Gansevoort RT; Schouten JP; Struck J; Navis G; Gans RO; van der Heide JJ; van Son WJ; Bakker SJ
    Transplantation; 2009 Jul; 88(2):279-87. PubMed ID: 19623026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome is related to long-term graft function in renal transplant recipients.
    Ozdemir FN; Karakan S; Akgul A; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2808-10. PubMed ID: 19765441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
    Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
    Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC; Zhu L; Terasaki PI; Everly MJ
    Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients.
    Rao PS; Schaubel DE; Jia X; Li S; Port FK; Saran R
    Am J Kidney Dis; 2007 Feb; 49(2):294-300. PubMed ID: 17261432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary potassium excretion, renal ammoniagenesis, and risk of graft failure and mortality in renal transplant recipients.
    Eisenga MF; Kieneker LM; Soedamah-Muthu SS; van den Berg E; Deetman PE; Navis GJ; Gans RO; Gaillard CA; Bakker SJ; Joosten MM
    Am J Clin Nutr; 2016 Dec; 104(6):1703-1711. PubMed ID: 27935524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
    Roberti I; Reisman L; Lieberman KV; Burrows L
    Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race effects.
    Koyama H; Cecka JM
    Clin Transpl; 1991; ():269-80. PubMed ID: 1820122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and staging of chronic kidney disease in renal transplant recipients.
    Costa de Oliveira CM; Mota MU; Mota RS; Nóbrega JO; Melo DS; Vieira AS; Fernandes PF; Campos Hde H; Evangelista JB
    Clin Transplant; 2009; 23(5):628-36. PubMed ID: 19563484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome after kidney transplantation in children with thrombotic risk factors.
    Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of predictors of long-term cadaveric renal allograft survival.
    Cole E; Naimark D; Aprile M; Wade J; Cattran D; Pei Y; Fenton S; Robinette M; Zaltsman J; Bear R
    Clin Transplant; 1995 Aug; 9(4):282-8. PubMed ID: 7579734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Systemic hypertension after kidney transplantation: associated risk factors and influence on graft survival].
    Chew-Wong A; Alberú-Gómez J; Abasta-Jiménez M; Márquez-Díaz F; Correa-Rotter R
    Gac Med Mex; 2005; 141(6):461-7. PubMed ID: 16381499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.